Paris, France and Camberley, UK – 13 May 2022 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s Annual General Meeting (“AGM”) will be held at 2pm CEST/1pm BST on 21 June 2022 as an open virtual meeting. Further details of the AGM will be provided
Visit PageCategory: Uncategorized
Full year 2021 results and update on growth strategy
Full year revenue and EBITDA in line with market expectations despite challenging and changing COVID-19 testing marketLeveraging core capabilities to become a leading, global clinical diagnostics company targeting annual revenues in excess of £100m in five years http://novacyt.com/wp-content/uploads/2022/04/Novacyt-Full-year-2021-results-and-update-on-growth-strategy.pdf
Visit PageDHSC dispute update
Paris, France and Camberley, UK – 26 April 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on its ongoing dispute with the Department of Health and Social Care (“DHSC”). http://novacyt.com/wp-content/uploads/2022/04/Novacyt-DHSC-dispute-update-1.pdf
Visit Page